Genetic association and bidirectional Mendelian randomization for causality between gut microbiota and six lung diseases
Frontiers in Medicine · 15.12.2023 · 10
DOI: 10.3389/fmed.2023.1279239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 15.12.2023. Verfasst von Yue Su und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Purposes Increasing evidence suggests that intestinal microbiota correlates with the pathological processes of many lung diseases. This study aimed to investigate the causality of gut microbiota and lung diseases.
Methods
Genetic information on intestinal flora and lung diseases [asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lower respiratory tract infection (LRTI), pulmonary arterial hypertension (PAH)] and lung function was obtained from UK Biobank, FinnGen, and additional studies. A Mendelian randomization (MR) analysis was conducted to explore the causal association between gut microbiota and lung diseases.
Results
The genetic liability to lung diseases may be associated with the abundance of certain microbiota taxa. Specifically, the genus Prevotella ( p = 0.041) was related to a higher risk of asthma; the family Defluviitaleaceae ( p = 0.002) and its child taxon were identified as a risk factor for chronic bronchitis; the abundance of the genus Prevotella ( p = 0.020) was related to a higher risk of ILD; the family Coriobacteriaceae ( p = 0.011) was identified to have a positive effect on the risk of LRTI; the genus Lactobacillus ( p = 0.0297) has been identified to be associated with an increased risk of PAH, whereas the genus Holdemanella ( p = 0.0154) presented a causal decrease in COPD risk; the order Selenomonadales was identified to have a positive effect on the risk of FEV1( p = 0.011). The reverse TSMR analysis also provided genetic evidence of reverse causality from lung diseases to the gut microbiota.
Conclusion
This data-driven MR analysis revealed that gut microbiota was causally associated with lung diseases, providing genetic evidence for further mechanistic and clinical studies to understand the crosstalk between gut microbiota and lung diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
- Health Science Center, Yangtze University, Hubei Province, Jingzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Su, Y., Zhang, Y., & Xu, J. (2023). Genetic association and bidirectional Mendelian randomization for causality between gut microbiota and six lung diseases. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1279239
Vancouver
Su Y, Zhang Y, Xu J. Genetic association and bidirectional Mendelian randomization for causality between gut microbiota and six lung diseases. Frontiers in Medicine. 2023;10. doi:10.3389/fmed.2023.1279239
BibTeX
@article{Su2023,
author = {Su, Yue and Zhang, Youqian and Xu, Jinfu},
title = {Genetic association and bidirectional Mendelian randomization for causality between gut microbiota and six lung diseases},
journal = {Frontiers in Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fmed.2023.1279239}
}
EUVIMED